Dr Jim Whittle
Jim is a medical oncologist specialising in neuro-oncology at the Peter MacCallum Cancer Centre. He completed his PhD at WEHI and was awarded the Professor Lynn Corcoran PhD Prize for his research understanding the molecular mechanisms responsible for resistance to cell death in breast cancer. This work has provided the foundation for testing novel compounds in early phase clinical trials.
In 2020, Jim commenced working remotely with the Ligon laboratory, Dana Faber Cancer Institute, with a focus on uncovering resistance mechanisms in glioma. In addition to making scientific discoveries, Jim is passionate about improving supportive care for brain cancer patients and their carers.